Can a pill save your sight? new trial targets blinding eye disease
NCT ID NCT05949593
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 3 trial tests whether a daily pill called tinlarebant can slow the growth of geographic atrophy, an advanced form of age-related macular degeneration that causes blind spots. About 429 adults with the condition will receive either the drug or a placebo for up to 2 years. The main goal is to see if the drug reduces the rate of vision loss.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tinlarebant (a tablet taken daily)
What this could lead to
If it works, this could slow vision loss from geographic atrophy, a leading cause of blindness in older adults.
What could go wrong
This is a late-stage trial, but the drug may not slow vision loss enough to matter. Side effects from daily medication are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Belite Study Site
Phoenix, Arizona, 85020, United States
-
Belite Study Site
Arcadia, California, 91007, United States
-
Belite Study Site
Beverly Hills, California, 90211, United States
-
Belite Study Site
Huntington Beach, California, 92467, United States
-
Belite Study Site
Los Angeles, California, 90033, United States
-
Belite Study Site
Palo Alto, California, 94303, United States
-
Belite Study Site
San Diego, California, 92093, United States
-
Belite Study Site
Lakeland, Florida, 33805, United States
-
Belite Study Site
Hagerstown, Maryland, 21740, United States
-
Belite Study Site
Saint Louis Park, Minnesota, 55416, United States
-
Belite Study Site
Westbury, New York, 11590, United States
-
Belite Study Site
Cary, North Carolina, 27511, United States
-
Belite Study Site
Durham, North Carolina, 27710, United States
-
Belite Study Site
Wake Forest, North Carolina, 27587, United States
-
Belite Study Site
Portland, Oregon, 97239, United States
-
Belite Study Site
Philadelphia, Pennsylvania, 19107, United States
-
Belite Study Site
Sewickley, Pennsylvania, 15143, United States
-
Belite Study Site
Germantown, Tennessee, 38138, United States
-
Belite Study Site
Abilene, Texas, 79606, United States
-
Belite Study Site
Dallas, Texas, 75231, United States
-
Belite Study Site
San Antonio, Texas, 78240, United States
-
Belite Study Site
Warrenton, Virginia, 20186, United States
-
Belite Study Site
Chatswood, New South Wales, 2067, Australia
-
Belite Study Site
Strathfield, New South Wales, 2135, Australia
-
Belite Study Site
Brisbane, Queensland, 4101, Australia
-
Belite Study Site
Adelaide, South Australia, 5000, Australia
-
Belite Study Site
East Melbourne, Victoria, 3002, Australia
-
Belite Study Site
Crawley, Western Australia, 6009, Australia
-
Belite Study Site
Beijing, Beijing Municipality, 100044, China
-
Belite Study Site
Chengdu, Sichuan, 610093, China
-
Belite Study Site
Beijing, 10005, China
-
Belite Study Site
Beijing, 100730, China
-
Belite Study Site
Guandong, 510060, China
-
Belite Study Site
Zhejiang, 325027, China
-
Belite Study Site
Ostrava, 70852, Czechia
-
Belite Study Site
Prague, 14000, Czechia
-
Belite Study Site
Prague, 14059, Czechia
-
Belite Study Site
Dijon, 21000, France
-
Belite Study Site
Écully, 69130, France
-
Belite Study Site
Lyon, 69317, France
-
Belite Study Site
Marseille, 130008, France
-
Belite Study Site
Basel, 4031, Switzerland
-
Belite Study Site
Lausanne, 1001, Switzerland
-
Belite Study Site
Taichung, 40447, Taiwan
-
Belite Study Site
Taipei, 100, Taiwan
-
Belite Study Site
Taoyuan, 33305, Taiwan
-
Belite Study Site
Great Yarmouth, NR31 6LA, United Kingdom
-
Belite Study Site
Harrow, HA1 3UJ, United Kingdom
-
Belite Study Site
London, EC1V 2PD, United Kingdom